uniQure N.V. Ordinary Shares vs Trane Technologies plc — how do they compare? uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B), while Trane Technologies plc trades at $471.29 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 71.1× uniQure N.V. Ordinary Shares's market cap, and Trane Technologies plc pays a 0.88% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals.
| QURE | TT | |
|---|---|---|
Market Cap | $1.48B | $105.17B |
Volume | 2,488,780 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $70.59 | $503.46 |
52-Week Low | $9.03 | $376.43 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $728.62M | $108.47B |
Dividend Yield | — | 0.88% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →